Acute obstetric coagulopathy during postpartum hemorrhage is caused by hyperfibrinolysis and dysfibrinogenemia: an observational cohort study.
de Lloyd L, Jenkins PV, Bell SF, Mutch NJ, Martins Pereira JF, Badenes PM, James D, Ridgeway A, Cohen L, Roberts T, Field V, Collis RE, Collins PW.
J Thromb Haemost. 2023 Apr;21(4):862-879. doi: 10.1016/j.jtha.2022.11.036. Epub 2022 Dec 22.
Postpartum Hemorrhage: Wherefore Art Thou, Hyperfibrinolysis?
Butwick AJ.
Anesth Analg. 2020 Nov;131(5):1370-1372. doi: 10.1213/ANE.0000000000004881.
Prevention and treatment of postpartum hemorrhage: focus on hematological aspects of management.
McLintock C.
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):542-546. doi: 10.1182/hematology.2020000139.
Clinical value of early assessment of hyperfibrinolysis by rotational thromboelastometry during postpartum hemorrhage for the prediction of severity of bleeding: A multicenter prospective cohort study in the Netherlands.
Tahitu M, Ramler PI, Gillissen A, Caram-Deelder C, Henriquez DDCA, de Maat MPM, Duvekot JJ, Eikenboom J, Bloemenkamp KWM, van den Akker T, van der Bom JG.
Acta Obstet Gynecol Scand. 2022 Jan;101(1):145-152. doi: 10.1111/aogs.14279. Epub 2021 Nov 3.
Perioperative hyperfibrinolysis - physiology and pathophysiology.
Marinho DS.
Braz J Anesthesiol. 2021 Jan-Feb;71(1):65-75. doi: 10.1016/j.bjane.2020.12.007. Epub 2020 Dec 25.
Coagulation management and transfusion in massive postpartum hemorrhage.
Massoth C, Wenk M, Meybohm P, Kranke P.
Curr Opin Anaesthesiol. 2023 Jun 1;36(3):281-287. doi: 10.1097/ACO.0000000000001258. Epub 2023 Feb 22.
Anaphylaxis-induced hyperfibrinolysis in pregnancy.
Truong HT, Browning RM.
Int J Obstet Anesth. 2015 May;24(2):180-4. doi: 10.1016/j.ijoa.2014.12.009. Epub 2015 Jan 8.
Tranexamic acid dose-response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study.
Ducloy-Bouthors AS, Gilliot S, Kyheng M, Faraoni D, Turbelin A, Keita-Meyer H, Rigouzzo A, Moyanotidou G, Constant B, Broisin F, Gouez AL, Favier R, Peynaud E, Ghesquiere L, Lebuffe G, Duhamel A, Allorge D, Susen S, Hennart B, Jeanpierre E, Odou P; TRACES working group.
Br J Anaesth. 2022 Dec;129(6):937-945. doi: 10.1016/j.bja.2022.08.033. Epub 2022 Oct 13.
Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis.
McCormack PL.
Drugs. 2012 Mar 26;72(5):585-617. doi: 10.2165/11209070-000000000-00000.
From appearance to essence: 10 years review of atypical amniotic fluid embolism.
Shen F, Wang L, Yang W, Chen Y.
Arch Gynecol Obstet. 2016 Feb;293(2):329-34. doi: 10.1007/s00404-015-3785-z. Epub 2015 Jun 20.
